ID: ALA554815

Max Phase: Preclinical

Molecular Formula: C11H10ClNO

Molecular Weight: 171.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.Oc1cccc(-c2cccnc2)c1

Standard InChI:  InChI=1S/C11H9NO.ClH/c13-11-5-1-3-9(7-11)10-4-2-6-12-8-10;/h1-8,13H;1H

Standard InChI Key:  YXARBZQTPFUZGQ-UHFFFAOYSA-N

Associated Targets(non-human)

Dopamine receptor 1304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 171.20Molecular Weight (Monoisotopic): 171.0684AlogP: 2.45#Rotatable Bonds: 1
Polar Surface Area: 33.12Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.78CX Basic pKa: 4.71CX LogP: 2.10CX LogD: 2.10
Aromatic Rings: 2Heavy Atoms: 13QED Weighted: 0.71Np Likeness Score: -0.37

References

1. Hacksell U, Arvidsson LE, Svensson U, Nilsson JL, Sanchez D, Wikström H, Lindberg P, Hjorth S, Carlsson A..  (1981)  3-Phenylpiperidines. Central dopamine-autoreceptor stimulating activity.,  24  (12): [PMID:6796690] [10.1021/jm00144a021]

Source